AB0407 IS THERE ANY DIFFERENCE BETWEEN SWITCHING AND CYCLING PATIENTS AFTER TUMOR NECROSIS FACTOR INHIBITOR (TNFi) FAILURE IN PSORIATIC ARTHRITIS? - CHARACTERIZATION OF A PORTUGUESE COHORT WITH ONE YEAR OF TREATMENT WITH TNFi AS THE FIRST BIOLOGICAL DMARD

Catarina Gomes(CUF Porto Hospital), Lúcia Costa(Hospital de São João), Isabel Kinney Ferreira de Miranda Santos, M. Bernardes, Tiago Beirão(Administração Regional de Saúde de Lisboa e Vale do Tejo), M. Diz Lopes
Annals of the Rheumatic Diseases
June 1, 2024
Cited by 1


Related Papers